Compare JUBILANT LIFE SCIENCES with SHASUN PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs SHASUN PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES SHASUN PHARMA JUBILANT LIFE SCIENCES/
SHASUN PHARMA
 
P/E (TTM) x 13.7 123.9 11.1% View Chart
P/BV x 1.7 8.5 20.1% View Chart
Dividend Yield % 0.9 0.2 373.2%  

Financials

 JUBILANT LIFE SCIENCES   SHASUN PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-19
SHASUN PHARMA
Mar-14
JUBILANT LIFE SCIENCES/
SHASUN PHARMA
5-Yr Chart
Click to enlarge
High Rs89894 953.3%   
Low Rs61846 1,354.2%   
Sales per share (Unadj.) Rs572.0214.2 267.1%  
Earnings per share (Unadj.) Rs36.25.3 678.9%  
Cash flow per share (Unadj.) Rs59.515.8 376.2%  
Dividends per share (Unadj.) Rs4.501.00 450.0%  
Dividend yield (eoy) %0.61.4 41.5%  
Book value per share (Unadj.) Rs301.953.3 566.0%  
Shares outstanding (eoy) m159.2856.62 281.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.30.3 405.9%   
Avg P/E ratio x20.913.1 159.7%  
P/CF ratio (eoy) x12.74.4 288.2%  
Price / Book Value ratio x2.51.3 191.5%  
Dividend payout %12.418.7 66.3%   
Avg Mkt Cap Rs m120,6943,958 3,049.6%   
No. of employees `0002.4NA-   
Total wages/salary Rs m19,2602,164 890.2%   
Avg. sales/employee Rs Th38,120.6NM-  
Avg. wages/employee Rs Th8,058.4NM-  
Avg. net profit/employee Rs Th2,414.3NM-  
INCOME DATA
Net Sales Rs m91,10812,127 751.3%  
Other income Rs m357229 155.8%   
Total revenues Rs m91,46612,356 740.2%   
Gross profit Rs m17,3901,009 1,723.4%  
Depreciation Rs m3,709594 624.8%   
Interest Rs m2,198415 529.5%   
Profit before tax Rs m11,840230 5,154.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00 0.0%   
Extraordinary Inc (Exp) Rs m-2,8020-   
Tax Rs m3,268-73 -4,493.9%   
Profit after tax Rs m5,770302 1,909.9%  
Gross profit margin %19.18.3 229.4%  
Effective tax rate %27.6-31.7 -87.2%   
Net profit margin %6.32.5 254.2%  
BALANCE SHEET DATA
Current assets Rs m45,8486,884 666.0%   
Current liabilities Rs m20,8978,456 247.1%   
Net working cap to sales %27.4-13.0 -211.3%  
Current ratio x2.20.8 269.5%  
Inventory Days Days5762 92.1%  
Debtors Days Days51108 47.4%  
Net fixed assets Rs m65,4984,970 1,317.8%   
Share capital Rs m159113 140.6%   
"Free" reserves Rs m47,9302,875 1,667.2%   
Net worth Rs m48,0893,020 1,592.3%   
Long term debt Rs m42,4291,817 2,334.6%   
Total assets Rs m114,68513,347 859.3%  
Interest coverage x6.41.6 411.2%   
Debt to equity ratio x0.90.6 146.6%  
Sales to assets ratio x0.80.9 87.4%   
Return on assets %6.95.4 129.3%  
Return on equity %12.010.0 119.9%  
Return on capital %12.413.3 93.2%  
Exports to sales %046.4 0.0%   
Imports to sales %014.2 0.0%   
Exports (fob) Rs mNA5,622 0.0%   
Imports (cif) Rs mNA1,728 0.0%   
Fx inflow Rs m12,4225,843 212.6%   
Fx outflow Rs m17,2272,173 792.7%   
Net fx Rs m-4,8053,669 -130.9%   
CASH FLOW
From Operations Rs m11,215398 2,820.7%  
From Investments Rs m-10,118-1,635 618.9%  
From Financial Activity Rs m6,5741,309 502.4%  
Net Cashflow Rs m7,61271 10,691.3%  

Share Holding

Indian Promoters % 45.6 39.2 116.3%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.6 241.7%  
FIIs % 21.2 17.6 120.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 39.6 53.3%  
Shareholders   23,815 20,750 114.8%  
Pledged promoter(s) holding % 15.9 12.3 129.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SUN PHARMA  WYETH LTD  ABBOTT INDIA  UNICHEM LAB  DR. REDDYS LAB  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Witness Selling; Sensex Down 235 Points(12:30 pm)

Share markets in India are presently trading on a negative note. Sectoral indices are trading on a mixed note with stocks in the IT sector.

Related Views on News

JUBILANT LIFE SCIENCES Announces Quarterly Results (2QFY20); Net Profit Up 18.9% (Quarterly Result Update)

Oct 31, 2019 | Updated on Oct 31, 2019

For the quarter ended September 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (up 18.9% YoY). Sales on the other hand came in at Rs 23 bn (down 0.2% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Sep 5, 2019 | Updated on Sep 5, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

JUBILANT LIFE SCIENCES Announces Quarterly Results (1QFY20); Net Profit Down 7.7% (Quarterly Result Update)

Jul 29, 2019 | Updated on Jul 29, 2019

For the quarter ended June 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 2 bn (down 7.7% YoY). Sales on the other hand came in at Rs 22 bn (up 5.0% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES Announces Quarterly Results (4QFY19); Net Profit Down 166.0% (Quarterly Result Update)

May 21, 2019 | Updated on May 21, 2019

For the quarter ended March 2019, JUBILANT LIFE SCIENCES has posted a net profit of Rs 1 bn (down 166.0% YoY). Sales on the other hand came in at Rs 24 bn (up 5.9% YoY). Read on for a complete analysis of JUBILANT LIFE SCIENCES's quarterly results.

JUBILANT LIFE SCIENCES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of JUBILANT LIFE SCIENCES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of JUBILANT LIFE SCIENCES. Also includes updates on the valuation of JUBILANT LIFE SCIENCES.

More Views on News

Most Popular

The Smartest Stock to Buy for 2020(Profit Hunter)

Nov 14, 2019

Small-cap stocks are selling at bargain prices today and are poised to generate a lot of wealth in 2020 and beyond...

A Trade that Could Generate Profits for Decades

Nov 14, 2019

India's #1 trader is back on the Investor Hour. Vijay Bhambwani talks to us about his super-profitable trading system and shares with us his #1 long term trade. Listen in...

The One Trade I'm Most Bullish on Now

Nov 12, 2019

A highly specific trade to potentially triple your money in just three months. You won't find this information anywhere else!

How the Modi Government is Helping My Top 7 Stocks(The 5 Minute Wrapup)

Nov 14, 2019

Recent reforms by the Modi government can give a big boost on your stocks, provided you buy the right ones.

I Think Nestle, HUL, and Asian Paints Could Give Low Returns(Profit Hunter)

Nov 15, 2019

If you think high quality stocks will continue their dream run forever, then you must read this now.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Nov 22, 2019 03:19 PM

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 8-QTR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS